Skip to main content

PharmacoEconomics

Ausgabe 8/2016

Inhalt (8 Artikel)

Current Opinion

Economic Evaluation of Vaccination Programmes in Older Adults and the Elderly: Important Issues and Challenges

Sevan Dirmesropian, James G. Wood, C. Raina MacIntyre, Philippe Beutels, Anthony T. Newall

Review Article

Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal—An Evidence Review Group Perspective

P. Thokala, E. L. Simpson, P. Tappenden, J. W. Stevens, K. Dickinson, S. Ryder, P. Harrison

Systematic Review

A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions

Catrin O. Plumpton, Daniel Roberts, Munir Pirmohamed, Dyfrig A. Hughes

Original Research Article

Cost Effectiveness of Protease Inhibitor Monotherapy Versus Standard Triple Therapy in the Long-Term Management of HIV Patients: Analysis Using Evidence from the PIVOT Trial

Lars Oddershede, Simon Walker, Wolfgang Stöhr, David T. Dunn, Alejandro Arenas-Pinto, Nicholas I. Paton, Mark Sculpher

Original Research Article

The Impact of Different DCE-Based Approaches When Anchoring Utility Scores

Richard Norman, Brendan Mulhern, Rosalie Viney

Open Access Original Research Article

Cost Utility of Omalizumab Compared with Standard of Care for the Treatment of Chronic Spontaneous Urticaria

Jonathan Graham, Doreen McBride, Donald Stull, Anna Halliday, Stamatia Theodora Alexopoulos, Maria-Magdalena Balp, Matthew Griffiths, Ion Agirrezabal, Torsten Zuberbier, Alan Brennan